These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 21627808)
1. Health service utilization in IBD: comparison of self-report and administrative data. Longobardi T; Walker JR; Graff LA; Bernstein CN BMC Health Serv Res; 2011 May; 11():137. PubMed ID: 21627808 [TBL] [Abstract][Full Text] [Related]
2. Self-reported Health Care Utilization of Patients with Inflammatory Bowel Disease Correlates Perfectly with Medical Records. Severs M; Petersen RE; Siersema PD; Mangen MJ; Oldenburg B Inflamm Bowel Dis; 2016 Mar; 22(3):688-93. PubMed ID: 26835981 [TBL] [Abstract][Full Text] [Related]
3. Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study. Yu Q; Zhu C; Feng S; Xu L; Hu S; Chen H; Chen H; Yao S; Wang X; Chen Y J Med Internet Res; 2021 Jan; 23(1):e20629. PubMed ID: 33399540 [TBL] [Abstract][Full Text] [Related]
4. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis. Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813 [TBL] [Abstract][Full Text] [Related]
5. Health care resource utilization in inflammatory bowel disease. Longobardi T; Bernstein CN Clin Gastroenterol Hepatol; 2006 Jun; 4(6):731-43. PubMed ID: 16631415 [TBL] [Abstract][Full Text] [Related]
6. Direct medical cost of managing IBD patients: a Canadian population-based study. Bernstein CN; Longobardi T; Finlayson G; Blanchard JF Inflamm Bowel Dis; 2012 Aug; 18(8):1498-508. PubMed ID: 22109958 [TBL] [Abstract][Full Text] [Related]
7. Trends in health-care costs and utilization for inflammatory bowel disease from 2010 to 2014 in Korea: A nationwide population-based study. Kim JW; Lee CK; Rhee SY; Oh CH; Shim JJ; Kim HJ J Gastroenterol Hepatol; 2018 Apr; 33(4):847-854. PubMed ID: 29055148 [TBL] [Abstract][Full Text] [Related]
8. A Phenome-Wide Analysis of Healthcare Costs Associated with Inflammatory Bowel Diseases. Cai W; Cagan A; He Z; Ananthakrishnan AN Dig Dis Sci; 2021 Mar; 66(3):760-767. PubMed ID: 32436120 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based Analysis. Targownik LE; Kaplan GG; Witt J; Bernstein CN; Singh H; Tennakoon A; Aviña Zubieta A; Coward SB; Jones J; Kuenzig ME; Murthy SK; Nguyen GC; Peña-Sánchez JN; Benchimol EI Am J Gastroenterol; 2020 Jan; 115(1):128-137. PubMed ID: 31895723 [TBL] [Abstract][Full Text] [Related]
10. The Relationship Between Adverse Childhood Experiences and Health Care Use in the Manitoba IBD Cohort Study. Witges KM; Bernstein CN; Sexton KA; Afifi T; Walker JR; Nugent Z; Lix LM Inflamm Bowel Dis; 2019 Sep; 25(10):1700-1710. PubMed ID: 30919910 [TBL] [Abstract][Full Text] [Related]
12. Health Care utilization in elderly onset inflammatory bowel disease: a population-based study. Nguyen GC; Sheng L; Benchimol EI Inflamm Bowel Dis; 2015 Apr; 21(4):777-82. PubMed ID: 25738376 [TBL] [Abstract][Full Text] [Related]
13. Health Services Use during Transition from Pediatric to Adult Care for Inflammatory Bowel Disease: A Population-Based Study Using Health Administrative Data. Zhao X; Bjerre LM; Nguyen GC; Mack DR; Manuel DG; Hawken S; Mojaverian N; Bollegala N; Benchimol EI J Pediatr; 2018 Dec; 203():280-287.e4. PubMed ID: 30266506 [TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of biologic versus non-biologic treatments and the health-related quality of life among a sample of patients with inflammatory bowel disease in a tertiary care center in Saudi Arabia. AlRuthia Y; Almadi M; Aljebreen A; Azzam N; Alsharif W; Alrasheed H; Almuaythir G; Saeed M; HajkhderMullaissa B; Alharbi O J Med Econ; 2020 Oct; 23(10):1102-1110. PubMed ID: 32619388 [TBL] [Abstract][Full Text] [Related]
15. Health Care Utilization Among U.S. Adults With Inflammatory Bowel Disease, 2015-2016. Terlizzi EP; Dahlhamer JM; Xu F; Wheaton AG; Greenlund KJ Natl Health Stat Report; 2021 Feb; (152):1-7. PubMed ID: 33663650 [TBL] [Abstract][Full Text] [Related]
16. Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease center: Access, resource utilization and outcomes. Nene S; Gonczi L; Kurti Z; Morin I; Chavez K; Verdon C; Reinglas J; Kohen R; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL World J Gastroenterol; 2020 Feb; 26(7):759-769. PubMed ID: 32116423 [TBL] [Abstract][Full Text] [Related]
17. Health Care Cost for Children Newly Diagnosed With Inflammatory Bowel Disease. Fondell AW; Mosha MH; Frank CR; Brangi JM; Hyams JS Inflamm Bowel Dis; 2020 Mar; 26(4):635-640. PubMed ID: 31504513 [TBL] [Abstract][Full Text] [Related]
18. Effect of Psychotherapy on Health Care Utilization in Children With Inflammatory Bowel Disease and Depression. Keerthy D; Youk A; Srinath AI; Malas N; Bujoreanu S; Bousvaros A; Keljo D; DeMaso DR; Szigethy EM J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):658-664. PubMed ID: 27035372 [TBL] [Abstract][Full Text] [Related]
19. Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases. Limsrivilai J; Stidham RW; Govani SM; Waljee AK; Huang W; Higgins PD Clin Gastroenterol Hepatol; 2017 Mar; 15(3):385-392.e2. PubMed ID: 27645518 [TBL] [Abstract][Full Text] [Related]
20. High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study. Murthy SK; James PD; Antonova L; Chalifoux M; Tanuseputro P PLoS One; 2017; 12(5):e0177211. PubMed ID: 28498877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]